Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment

Molecular Vision

Volumn 17, Issue , 2011, Pages 680-692

  Barathi, V A ^a   Beuerman, Roger W ^a,b,c  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATROPINE; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER DEPTH; ARTICLE; CONTROLLED STUDY; CORNEA CURVATURE; CORNEA THICKNESS; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; EMMETROPIA; EYE AXIS LENGTH; EYE REFRACTION; GENE EXPRESSION REGULATION; LENS; MOLECULAR MECHANICS; MORNING DOSAGE; MOUSE; MYOPIA; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINAL THICKNESS; SPECTACLES; UPREGULATION; VISUAL SYSTEM PARAMETERS; VITREOUS BODY;

ANIMALS; ATROPINE; BLOTTING, NORTHERN; FIBROBLASTS; GENE EXPRESSION REGULATION; LENS, CRYSTALLINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOPIA; RECEPTORS, MUSCARINIC; REFRACTIVE ERRORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERA; SODIUM CHLORIDE; VITREOUS BODY;

EID: 79952854879     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Funata M, Tokoro T. Scleral change in experimentally myopic monkeys. Graefes Arch Clin Exp Ophthalmol 1990; 228:174-9. [PMID: 2338255]
2. Norton TT. Experimental myopia in tree shrews. Ciba Found Symp 1990; 155:178-94. [PMID: 2088676]
3. McBrien NA, Gentle A. The role of visual information in the control of scleral matrix biology in myopia. Curr Eye Res 2001; 23:313-9. [PMID: 11910519]
4. McBrien NA, Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res 2003; 22:307-38. [PMID: 12852489]
5. Shih YF, Chen CH, Chou AC. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 1999; 15:85-90. [PMID: 10048351]
6. Chou AC, Shih YF, Ho TC, Lin LL. The effectiveness of 0.5% atropine in controlling high myopia in children. J Ocul Pharmacol Ther 1997; 13:61-7. [PMID: 9029440]
7. Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, Tan DT. Atropine for the Treatment of Childhood Myopia. Ophthalmology 2006; 113:2285-91. [PMID: 16996612]
8. Barathi VA, Weon SR, Beuerman RW. Expression of muscarinic receptors inhuman and mouse sclera and their role in the regulation of sclera fibroblast proliferation. Mol Vis 2009; 15:1277-93. [PMID: 19578554]
9. Barathi VA, Beuerman RW. Muscarinic mechanisms in a mouse model of myopia. Ophthalmic Physiol Opt 2006; 26:19. [PMID: 16390478]
10. Mckanna JA, Casagrande VA. Chronic cycloplegia prevents lid-suture myopia in tree shrews. Invest Ophthalmol Vis Sci 1985; 26:331.
11. Schwahn HN, Kaymak H, Schaeffel F. Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick. Vis Neurosci 2000; 17:165-76. [PMID: 10824671]
12. Wildsoet CG, McBrien NA, Clark IQ. Atropine inhibition of lens-induced effects in chick: evidence for similar mechanisms underlying form deprivation and lens induced myopia. Invest Ophthalmol Vis Sci 1994; 35:2068.
13. Tigges M, Iuvone PM, Fernandes A, Sugrue MF, Mallorga PJ, Laties AM, Stone RA. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci 1999; 76:397-407. [PMID: 10416935]
14. Barathi VA, Boopathi VG, Yap ETH, Beuerman RW. Two models of experimental myopia in mouse. Vision Res 2008; 48:904-16. [PMID: 18289630]
15. Schaeffel F, Burkhardt E, Howland HC, Williams RW. Measurement of refractive state and deprivation myopia in two strains of mice. Optom Vis Sci 2004; 81:99-110. [PMID: 15127929]
16. Saw SM, Gazzard G, Au Eong KG, Tan DT. Myopia: attempts to arrest progression. Br J Ophthalmol 2002; 86:1306-11. [PMID: 12386095]
17. Tong L, Huang XL, Koh AL, Zhang X, Tan DT, Chua WH. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology 2009; 116:572-9. [PMID: 19167081]
18. Tan DT, Lam DS, Chua WH, Shu-Ping DF, Crockett RS, Asian Pirenzepine Study Group. One-year multicenter, doublemasked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmol 2005; 112:84-91. [PMID: 15629825]
19. Yin GC, Gentle A, McBrien NA. Muscarinic antagonist control of myopia: a molecular search for the M1 receptor in chick. Mol Vis 2004; 10:787-93. [PMID: 15525903]
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9. [PMID: 2440339]
21. Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene 2002; 21:8272-81. [PMID: 12447690]
22. Brink N, Szamel M, Young AR, Wittern KP, Bergemann J. Comparative quantification of IL-1, IL-10, Il-10r, TNF and IL-7 mRNA levels in UV-irradiated human skin in vivo. Inflamm Res 2000; 49:290-6. [PMID: 10939619]
23. Barathi VA, Beuerman RW, Schaeffel F. Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice. Vision Res 2009; 49:383-7. [PMID: 19059278]
24. Schaeffel F, Burkhardt E. Pupillographic evaluation of the time course of atropine effects in the mouse eye. Optom Vis Sci 2005; 82:215-20. [PMID: 15767877]
25. Duncan G, Collison DJ. Role of the non-neuronal cholinergic system in the eye: a review. Life Sci 2003; 72:2013-9. [PMID: 12628451]
26. Raviola E, Wiesel TN. Neural control of eye growth and experimental myopia in primates. Ciba Found Symp 1990; 155:22-38. [PMID: 2088678]
27. Sivak JG, Barrie DL, Callender MG, Doughty MJ, Seltner RL, West JA. Optical causes of experimental myopia. Ciba Found Symp 1990; 155:160-72. [PMID: 2088675]
28. Wallman J. Retinal influences on sclera underlie visual deprivation myopia. Ciba Found Symp 1990; 155:126-34. [PMID: 2088673]
29. Lawrence MS, Azar DT. Myopia and models and mechanisms of refractive error control. Ophthalmol Clin North Am 2002; 15:127-33. [PMID: 12064076]
30. Cottriall CL, McBrien NA. The M (1) muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest Ophthalmol Vis Sci 1996; 37:1368-79. [PMID: 8641840]
31. Raviola E, Wiesel TN. An animal model of myopia. N Engl J Med 1985; 312:1609-15. [PMID: 4000200]
32. Ashkenazi A, Ramachandran J, Capon DJ. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature 1989; 340:146-50. [PMID: 2739737]
33. Bedrossian RH, The effect of atropine on myopia.Am J Ophthalmol1979867137. 545205
34. Brenner RL. Further observations on use of atropine in the treatment of myopia. Ann Ophthalmol 1985; 17:137-40. [PMID: 3994212]
35. Lind GJ, Chew SJ, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci 1998; 39:2217-31. [PMID: 9804129]
36. McBrien NA, Metlapally R, Jobling AL, Gentle A. Expression of collagen-binding integrin receptors in the mammalian sclera and their regulation during the development of myopia. Invest Ophthalmol Vis Sci 2006; 47:4674-82. [PMID: 17065473]
37. Kusakari T, Sato T, Tokoro T. Regional scleral changes in form-deprivation myopia in chicks. Exp Eye Res 1997; 64:465-76. [PMID: 9196399]
38. Rada JA, Mathews AL, Brenza H. Regional proteoglycan synthesis in the sclera of experimentally myopic chicks. Exp Eye Res 1994; 59:747-60. [PMID: 7698268]
39. Gottlieb MD, Joshi HB, Nickla DL. Scleral changes in chicks with form-deprivation myopia. Curr Eye Res 1990; 12:1157-65.
40. Wall SJ, Yasuda RP, Li M, Ciesla W, Wolfe BB. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration. J Pharmacol Exp Ther 1992; 262:584-8. [PMID: 1323653]
41. Siman RG, Klein WL. Cholinergic activity regulates muscarinic receptors in central nervous system cultures. Proc Natl Acad Sci USA 1979; 76:4141-5. [PMID: 226997]
42. McKinney M, Robbins M. Chronic atropine administration up-regulates rat cortical muscarinic m1 receptor mRNA molecules: assessment with the RT/PCR. Brain Res Mol Brain Res 1992; 12:39-45. [PMID: 1372072]
43. Waelbroeck M, Tastenoy M, Camus J, Christophe J. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol 1990; 38:267-73. [PMID: 2385234]
44. Fukamauchi F, Saunders PA, Hough C, Chuang DM. Agonist-induced down-regulation and antagonist-induced up-regulation of m2-and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol Pharmacol 1993; 44:940-9. [PMID: 8246917]
45. Fukamauchi F, Hough C, Chuang DM. Expression and agonist-induced down-regulation of mRNAs of m2-and m3-muscarinic acetylcholine receptors in cultured cerebellar granule cells. J Neurochem 1991; 56:716-9. [PMID: 1988565]
46. Witt-Enderby PA, Yamamura HL, Halonen M, Lai J, Palmer JD, Bloom JW. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment. Mol Pharmacol 1995; 47:485-90. [PMID: 7700247]
47. Liu Q, Wu J, Wang X, Zeng J. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs. Mol Vis 2007; 13:1234-44. [PMID: 17679952]